Get informed when a big investor buys or sells
+ FollowUndervalued by 84.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $13.21 Billion |
|---|---|
| Enterprise Value | $16.37 Billion |
| Annual dividend | $1.73 |
| Dividend yield | 6.65% |
| Earnings per Share | $0.91 |
| Beta | 0.22 |
| Outstanding Shares | 527,323,999 |
| P/E Ratio | 17.21 |
|---|---|
| PEG | 4.36 |
| Price to Sales | 1.35 |
| Price to Book Ratio | 1.21 |
| Enterprise Value to Revenue | 1.75 |
| Enterprise Value to EBIT | 21.82 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.38 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
UPM-Kymmene Oyj is a prominent player in the forest-based bioindustry sector. Its diverse operations are organized into key segments: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, UPM Plywood,...